BIT's 8th Annual International Congress of Medichem- 2019 (ICM-2019)
Highlights of the ICM-2019

• Designing 40+ Hot Sessions of Scientific Forums, Dialogs and Roundtables
• Shooting for 200+ Oral Presentations in Whole Medicinal Chemistry Fields
• Gathering 50+ Posters and Exhibitors in Cutting-edge Technologies and Novel Methods
• Bringing in 20+ Professional Media Supporters
• Experiencing a Cultural Atmosphere of Nanjing

Our Renowned Speakers
Dr. Dave Madge, VP, Research Service Division, WuXi AppTec, Inc., China Dr. Jeff Reaga, Scientific Director, Amgen, USA Dr. Robert Plumb, Director of Metabolic Phenotyping and Stratified Medicine,Waters Corporation, USA
Dr. Le Sun, President & CEO, AbMax Biotechnology, China Dr. Kiyoshi Nokihara, CEO & CSO, HiPep Laboratories, Japan Dr. Xian Bu, Co-Founder and Managing Director, SYNthesis med chem, USA
Dr. Laure Bouchez, Director, Glenmark Therapeutics, USA Dr. Wei Zhang, Associate Professor, University of Massachusetts Boston, USA Dr. Jiren Zhang, Professor, Oncology Center, ZhuJiang Hospital of Southern Medical University, China
Dr. Kevin Liu, Head of Chemistry, Global Discovery Chemistry, Novartis Institute of Biomedical Research, China Dr. Hakim Mohamed, President and CEO, Once Source Clinical & Management, USA Dr. Henrietta Ukwu, Senior Vice President, Head of Global Regulatory Affairs,Otsuka,USA
Dr. Maode Lai, Academician of Nationale Akademie der Wissenschafte, President, China Pharmaceutical University, China Dr. Christopher Abell, Fellow of the Royal Society, Pro-Vice-Chancellor for Research,The University of Cambridge,UK Dr. Richard Soll, Senior Vice President and Head of International Discovery Service Unit,WuXi AppTec, USA
Dr. Jan Hoflack, Chief Scientific and Operational Officer, Oncodesign SA, France Dr. Howard J. Federoff, Vice Chancellor of Health Affairs and Chief Executive Officer of Health System, University of California, Irvine, USA Dr. Litao Zhang, Vice President, Leads Discovery and Optimization, Bristol-Myers Squibb, USA
Dr. Tom Mander, Chief Operating Officer, Domainex Ltd., UK Dr. Bruce Given, COO, Arrowhead Research Corporation, USA Dr. Chris H. Senanayake, Vice President, Boehringer Ingelheim Pharmaceuticals, Inc., USA
Dr. Tina Tao, Head of APAC E2E Biodevelopment Center, Merck Group, China Dr. John Lambert, Corporate Vice President and Chief Medical Officer, PAREXEL International Shanghai, China Dr. Gerald J. Yakatan, Chairman & CEO, IriSys, LLC,.USA
Dr. Akiyoshi Suganuma, Group Officer and President of BA-CFU, Medicine Development Center, Eisai Co., Ltd., Japan Dr. David C. Bunton, CEO, REPROCELL Europe Ltd., UK Dr. Steffen Denzinger, Director, Strategy and Business Development Process Solutions, Merck Millipore, Germany
Dr. Eric Westhof, Academician, Vice President for Research and Doctoral Studies of the University of Strasbourg, France Dr. Wei Li, Professor and Director of UTCoP Drug Discovery Center, University of Tennessee Health Science Center, USA Dr. A. Vieira, Director, Metabolic Research Lab, Simon Fraser University, Canada
Dr. Dieter Lubda, Head Actives Formulation RD Operations, Life Science | Process Solutions | Actives Formulation, Merck, Germany Dr. Jeffery Liu, Director, GSK, USA Dr. Guo-Ping Zhou, Adjunct Professor, Harvard Medical School, USA
Program at a Glance
Program Layout
说明: 0
Stream 0: Leadership Summit
-Opening and Keynote Forum
说明: 1
Stream 1: Innovative Forum
-Emerging Drug Targets
说明: 2
Stream 2: E-Symposia
- Drug Design, Screening and Hit to Lead
说明: 3
Stream 3: Discovery Workshop
- New Modalities of Medicinal Chemistry
说明: 4
Stream 4: X Lab
-New Technologies and Processes of Drug Synthesis
说明: 5
Stream 5: Trial Center
-ADMET in Medicinal Chemistry
说明: 6
Stream 6: P-Zone
-Next Generation Drug Pipelines
说明: 9
Stream 7: S & T Hub
- Research Frontiers and Tech Innovation
说明: 7
Stream 8: Training Camp
- Training Courses
说明: 8
Stream 9: Showtime Square
-Papers, Posters and Exhibition
说明: Joint Events-1
Stream 10: Joint Events
-Concurrent Conference
说明: Joyful Commune B
Stream 11: Joyful Commune
-Social and Cultural Activities
Sponsors & Exhibitors
Sponsors Exhibitors

● Sponsorship provides a great means of broadening your competitive edge by improving your company's image, prestige and credibility by supporting events that your target market finds attractive.

● This conference provides your company with an unparalleled marketing opportunity to get before industry decision-makers. Exhibiting at the right exhibition can be one of the most efficient, effective and successful marketing activities available to you.

More More
Scenery of Xiamen
News Updates
ͼ�� Speaking Proposals are Now Being Accepted
ͼ�� Call for Exhibitors and Sponsors
ͼ�� Call for Collaborative Partners, Media and Journals
Concurrent Conferences

BIT’s 17th Annual International Congress of Drug Discovery Science & Technology
Hosting Organization

Jiangsu Pharmaceutical Association
Operating Organizations

Information Research Center of International Talent, SAFEA

BIT Group Global Ltd.
Official Travel Agency

BIT World Travel Service, Inc.

BIT's Upcoming Events


Contact Us

Copyright © 2009-2019, BIT Congress Inc.
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China